Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

4MRE

Crystal structure of the murine CD44 hyaluronan binding domain complex with a small molecule

Summary for 4MRE
Entry DOI10.2210/pdb4mre/pdb
Related4MRD 4MRF 4MRG 4MRH 4NP2 4NP3
DescriptorCD44 antigen, DIMETHYL SULFOXIDE, 3-methylbenzene-1,2-diamine, ... (4 entities in total)
Functional Keywordslink module, cell receptor, hyaluronan binding, cell surface, cell adhesion-inhibitor complex, cell adhesion/inhibitor
Biological sourceMus musculus (mouse)
Cellular locationCell membrane; Single-pass type I membrane protein: P15379
Total number of polymer chains1
Total formula weight16924.91
Authors
Liu, L.K.,Finzel, B. (deposition date: 2013-09-17, release date: 2014-04-16, Last modification date: 2023-09-20)
Primary citationLiu, L.K.,Finzel, B.C.
Fragment-Based Identification of an Inducible Binding Site on Cell Surface Receptor CD44 for the Design of Protein-Carbohydrate Interaction Inhibitors.
J.Med.Chem., 57:2714-2725, 2014
Cited by
PubMed Abstract: Selective inhibitors of hyaluronan (HA) binding to the cell surface receptor CD44 will have value as probes of CD44-mediated signaling and have potential as therapeutic agents in chronic inflammation, cardiovascular disease, and cancer. Using biophysical binding assays, fragment screening, and crystallographic characterization of complexes with the CD44 HA binding domain, we have discovered an inducible pocket adjacent to the HA binding groove into which small molecules may bind. Iterations of fragment combination and structure-driven design have allowed identification of a series of 1,2,3,4-tetrahydroisoquinolines as the first nonglycosidic inhibitors of the CD44-HA interaction. The affinity of these molecules for the CD44 HA binding domain parallels their ability to interfere with CD44 binding to polymeric HA in vitro. X-ray crystallographic complexes of lead compounds are described and compared to a new complex with a short HA tetrasaccharide, to establish the tetrahydroisoquinoline pharmacophore as an attractive starting point for lead optimization.
PubMed: 24606063
DOI: 10.1021/jm5000276
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.58 Å)
Structure validation

226707

PDB entries from 2024-10-30

PDB statisticsPDBj update infoContact PDBjnumon